Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
Andrea Loehr, Akash Patnaik, David Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
The New England Journal of Medicine
|
February 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate Cancer
Karim Fizazi, Josep M Piulats, M Neil Reaume, et al.
European Urology
|
May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer
Luka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
European Urology
|
June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer
Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Science (New York, N.Y.)
|
May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Fanying Tang, Duo Xu, Shangqian Wang, et al.
Cancer Cell
|
July 18, 2020
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
Zeda Zhang, Wouter R Karthaus, Young Sun Lee, et al.
Cancer Cell
|
March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
Andrea Loehr, Akash Patnaik, David Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
The New England Journal of Medicine
|
February 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate Cancer
Karim Fizazi, Josep M Piulats, M Neil Reaume, et al.
European Urology
|
May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer
Luka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
European Urology
|
June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer
Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Science (New York, N.Y.)
|
May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Fanying Tang, Duo Xu, Shangqian Wang, et al.
Cancer Cell
|
July 18, 2020
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
Zeda Zhang, Wouter R Karthaus, Young Sun Lee, et al.
Cancer Cell
|
March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Page
of 9